HALO vs TJX · P/E 15, rev $857.7M vs P/E 32, rev $29.50B
Halozyme Therapeutics Inc (HALO) versus The TJX Companies Inc (TJX) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE. It is led by Ernie L. Herrman.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
Not investment advice. Open the HALO and TJX stock pages for the full models.
Not investment advice.